LifeStance Health Group, Inc. (LFST) Return on equity 2021–2025
LifeStance Health Group, Inc. (LFST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
0.6%FY2025 · since FY2021: -19.9% → 0.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.6% | +4.6 pp |
| FY2024 | -4.0% | +9.1 pp |
| FY2023 | -13.0% | +1.2 pp |
| FY2022 | -14.2% | +5.7 pp |
| FY2021 | -19.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LFST financial trends
LFST RevenueLFST Net incomeLFST Net marginLFST Gross profitLFST Gross marginLFST Operating incomeLFST Operating marginLFST Operating cash flowLFST Free cash flowLFST Capital expendituresLFST Stock buybacksLFST Dividends paidLFST Total assetsLFST Total liabilitiesLFST Shareholders’ equityLFST overview →